
Ramose Pharmaceutical Private Limited
About Ramose Pharmaceutical Private Limited
Data last updated:
Ramose Pharmaceutical Private Limited is a private limited company based in Patna, Bihar, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 November 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U51909BR2016PTC032868. Its GSTIN is 10AAHCR9983M1ZQ (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Vijay Kumar and Sunita.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Anand Brij Sarojini Enclave E F/No – 50 Karbigahiya, Patna, Bihar, India – 800001.
As per the financials filed for FY 2021, the company reported a revenue of ₹12.2 Lakh, a decline of 71% compared to the previous year. For the same year it recorded a net loss of ₹2.61 Lakh (net margin -21.4%) and EBITDA of -₹1.53 Lakh (EBITDA margin -12.5%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ramose Pharmaceutical Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressAnand Brij Sarojini Enclave E F/No – 50 Karbigahiya, Patna, Bihar, India – 800001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ramose Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ramose Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ramose Pharmaceutical Private Limited, buy the company report.
Financials of Ramose Pharmaceutical Private Limited
FY 2021 filings availableRamose Pharmaceutical Private Limited reported revenue of ₹12.2 Lakh (down 71% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 1% over three years, including a 71% fall in the latest year. EBITDA fell 262% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.53 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.61 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -12.5% | ||||
| Net Profit Margin | -21.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ramose Pharmaceutical Private Limited, buy the company report.
Board of directors of Ramose Pharmaceutical Private Limited
Ramose Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijay Kumar | Director | 10 Nov 2016 | 10 Years 0 Months | Current |
| Sunita | Director | 10 Nov 2016 | 10 Years 0 Months | Current |
Peer comparison
Ramose Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Durgesh Rice Mill Private Limited | ₹12.21 Lakh (FY 2024) | 1.0% | Burdwan, West Bengal, India | |||
| Swarikshit Agro Producer Company Limited | ₹12.21 Lakh (FY 2023) | -26.0% | Pandharpur, Maharashtra, India | |||
| Gama Medichem Healthcare Private Limited | ₹12.21 Lakh (FY 2016) | -41.0% | Bahraich, Uttar Pradesh, India | |||
| Zelbion Biomerg Private Limited | ₹12.2 Lakh (FY 2024) | -27.0% | Cantt, Uttar Pradesh, India | |||
| Kotam Ayurved Private Limited | ₹12.2 Lakh (FY 2018) | 117.0% | New Delhi, Delhi, India | |||
| Ramose Pharmaceutical Private Limitedthis company | ₹12.2 Lakh (FY 2021) | -₹2.61 Lakh | -21.4% | -71.0% | Patna, Bihar, India | |
| Moseley Pharmaceuticals Private Limited | ₹12.2 Lakh (FY 2025) | -59.0% | Lucknow, Uttar Pradesh, India | |||
| Mahit Traders Private Limited | ₹12.2 Lakh (FY 2017) | Delhi, India | ||||
| Shamlal Company India Private Limited | ₹12.2 Lakh (FY 2021) | -68.0% | Salem, Tamil Nadu, India | |||
| PDL Life Sciences Private Limited | ₹12.2 Lakh (FY 2023) | -50.0% | Hyderabad, Telangana, India | |||
| Olestra Lifesciences Private Limited | ₹12.19 Lakh (FY 2017) | -41.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Ramose Pharmaceutical Private Limited, buy the company report.
Auditor
Ramose Pharmaceutical Private Limited is audited by RSRKUMARANDASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RSRKUMARANDASSOCIATES | FY 2017 | 017968C |
Shareholding
The shareholding of Ramose Pharmaceutical Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Ramose Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Mar 2018 | 100183135 | State Bank of India | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Ramose Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ramose Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ramose Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAHCR9983M1ZQ | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ramose Pharmaceutical Private Limited, buy the company report.
Recent activity
Ramose Pharmaceutical Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Sunita was appointed as Director on 10 Nov 2016.
Frequently asked questions
Ramose Pharmaceutical is an active private limited company based in Patna, Bihar, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 November 2016 (10+ years old) and is registered under CIN U51909BR2016PTC032868.
Ramose Pharmaceutical has 2 current directors:
- Vijay Kumar - Director
- Sunita - Director
The latest financial statements of Ramose Pharmaceutical on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Ramose Pharmaceutical is 10AAHCR9983M1ZQ, registered in Bihar.
The CIN (Corporate Identification Number) of Ramose Pharmaceutical is U51909BR2016PTC032868. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ramose Pharmaceutical was incorporated on 10 November 2016, making it 10+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Ramose Pharmaceutical by revenue are Durgesh Rice Mill Private Limited, Swarikshit Agro Producer Company Limited, Gama Medichem Healthcare Private Limited, Zelbion Biomerg Private Limited, Kotam Ayurved Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Sunita was appointed as Director on 10 Nov 2016. Vijay Kumar was appointed as Director on 10 Nov 2016.
The registered office of Ramose Pharmaceutical is at Anand Brij Sarojini Enclave E FNo – 50 Karbigahiya, Patna, Bihar, India – 800001.
Ramose Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Ramose Pharmaceutical has open charges of ₹10 Lakh and no satisfied charges on record as per latest MCA filings.

